Miller Sandra C
Department of Anatomy and Cell Biology, McGill University Montreal, Quebec, Canada.
Evid Based Complement Alternat Med. 2005 Sep;2(3):309-14. doi: 10.1093/ecam/neh118.
Echinacea has been viewed as an immunoenhancing herb since it became commercially available several years ago. Indeed, its medicinal significance is responsible for billions of dollars in worldwide sales annually. Unfortunately, most of the 'evidence' for the purported medicinal efficacy of Echinacea has been anecdotal and, moreover, to this day, there is no formal proof on how to achieve the best results-whether it should be consumed daily throughout life as a prophylactic; consumed by either young or old; or consumed after diseases, such as cancer, have taken hold. Our work over the past 5 years has led to conclusive answers to some of these questions, at least in mice. Our results have shown that daily consumption of Echinacea is indeed prophylactic, extends the life span of aging mice, significantly abates leukemia and extends the life span of leukemic mice. Given that humans are 97% genetically common with mice and that virtually all our basic physiology is identical, it is neither unjustified to extrapolate these observations to humans nor would it be an arduous task to perform many of these studies in humans, thus establishing viable scientific evidence replacing the anecdotal.
自紫锥菊几年前开始商业化销售以来,它一直被视为一种能增强免疫力的草药。事实上,它的药用价值每年在全球范围内创造了数十亿美元的销售额。不幸的是,大多数关于紫锥菊所谓药用功效的“证据”都只是传闻,而且直到如今,对于如何取得最佳效果仍没有正式的证据——是应该作为预防措施终生每日服用;是年轻人或老年人都可以服用;还是在诸如癌症等疾病发病后服用。我们过去5年的研究至少在小鼠身上对其中一些问题得出了确凿的答案。我们的研究结果表明,每日服用紫锥菊确实具有预防作用,能延长衰老小鼠的寿命,显著减轻白血病症状并延长患白血病小鼠的寿命。鉴于人类与小鼠在基因上有97%的共性,而且我们几乎所有的基本生理机能都相同,将这些观察结果外推至人类并非毫无根据,在人类身上开展许多此类研究也并非艰巨任务,这样就能建立起可行的科学证据来取代传闻证据。